Tao Ji

Tao Ji has extensive work experience in the pharmaceutical and biotechnology industry. Tao is currently working at Allorion Therapeutics as the Senior Director and Head of DMPK and Clinical Pharmacology. Prior to this, they worked at EMD Serono, Inc. as the Director of Clinical Pharmacology.

Tao Ji spent a significant portion of their career at Incyte, where they held several roles including Director, Senior Principal Investigator, and Principal Investigator. Tao also worked at Novartis Institutes for BioMedical Research (NIBR) as an Investigator III and at Genentech as an Associate Scientist.

In addition, Tao Ji has academic experience as a Fellow at the University at Buffalo and as a Postdoctoral Researcher at The University of Kansas. Tao also worked as a Research Scientist at Eli Lilly and Company and QPS Holdings, LLC.

Throughout their career, Tao Ji has been involved in various research and leadership positions, focusing on DMPK and clinical pharmacology.

Tao Ji earned a Bachelor of Science (BS) degree in Medicinal Chemistry from West China University of Medical Sciences, where they studied from 1989 to 1993. Tao later pursued further education and obtained a Ph.D from the University at Buffalo, attending from 2000 to 2005. The field of study for their Ph.D is not specified.